All Categories
Featured
Safety Of Low Dose Cannabidiol in North-Charleston-South-Carolina
At low concentrations (sub-micromolar scale), CBD binds to equilibrative nucleoside transporter (ENT), transient receptor potential melastatin type 8 (TRPM8),...
Open Label Study Of Cannabidiol In Parkinson's Disease in Washington-District-of-Columbia
At low concentrations (sub-micromolar scale), CBD binds to equilibrative nucleoside transporter (ENT), transient receptor potential melastatin type 8 (TRPM8),...
Safety And Tolerability Of Cannabidiol In Parkinson Disease: An ... in Moreno-Valley-California
Studies show that CBD can increase AEA concentration by blocking the AEA membrane transporter (AMT) or the FAAH enzyme, which catalyzes AEA hydrolysis.Cannabinoids in...
Cannabidiol (Cbd) Consideration In Parkinson Disease in Charleston-South-Carolina
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.IJMS Free Full-Text...
2021 Research Advisory Panel Of California in Moreno-Valley-California
At low concentrations (sub-micromolar scale), CBD binds to equilibrative nucleoside transporter (ENT), transient receptor potential melastatin type 8 (TRPM8), serotonin 1A receptor (5-HT1A),...
State Of Cbd: Thoughts From A Prescriber - Neurology Live in Centennial-Colorado
An open-label pilot study conducted in PD patients showed that oral doses of CBD ranging from 150-400 mg/day, combined with classic antiparkinsonian agents, reduced...
Open Label Study Of Cannabidiol In Parkinson's Disease in San-Bernardino-California
Studies show that CBD can increase AEA concentration by blocking the AEA membrane transporter (AMT) or the FAAH enzyme, which catalyzes AEA...
Role Of Cannabidiol For Improvement Of The Quality Of ... - Mdpi in Oxnard-California
Studies show that CBD can increase AEA concentration by blocking the AEA membrane transporter (AMT) or the FAAH enzyme,...
Gb - Eu Clinical Trials Register in Philadelphia-Pennsylvania
Studies show that CBD can increase AEA concentration by blocking the AEA membrane transporter (AMT) or the FAAH enzyme, which catalyzes AEA hydrolysis.IJMS Free Full-Text...
Parkinson's Disease & Movement Disorders Institute in Knoxville-Tennessee
An open-label pilot study conducted in PD patients showed that oral doses of CBD ranging from 150-400 mg/day, combined with classic antiparkinsonian agents, reduced psychotic...
Navigation
Latest Posts
Safety Of Low Dose Cannabidiol in North-Charleston-South-Carolina
Open Label Study Of Cannabidiol In Parkinson's Disease in Washington-District-of-Columbia
Safety And Tolerability Of Cannabidiol In Parkinson Disease: An ... in Moreno-Valley-California
